NFG
WHWK

Next Financial Group’s Whitehawk Therapeutics WHWK Stock Holding History

Next Financial Group’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$3K – 3003
2021
Q3 		$3K Hold
100
– – ﹤0.01% 2423
2021
Q2 		$3K Buy
+100
New +$2.28K ﹤0.01% 2361

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

Next Financial Group's WHWK Position: Q4 2021 in Review

Next Financial Group sold out of Whitehawk Therapeutics (WHWK) in Q4 2021, closing a stake of 100 shares — an estimated $3K sold.

Next Financial Group first reported a position in WHWK in Q2 2021 and held it in 2 quarters. The position peaked at $3K in Q3 2021. 46 funds tracked by Wall St. Rank hold WHWK as of Q4 2021.

  • Next Financial Group reported no remaining Whitehawk Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Next Financial Group sold 100 Whitehawk Therapeutics shares in Q4 2021, an estimated $3K.
  • Next Financial Group first reported a position in Whitehawk Therapeutics in Q2 2021 and held it in 2 quarters.
  • Next Financial Group's Whitehawk Therapeutics position peaked at $3K in Q3 2021.
  • 46 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.